{"name":"Bernd Jilma","slug":"bernd-jilma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQWFd0TGZVYkFhMVN4dmxCMERzaV96ZFQxSWRTLXRoMUNqYlJoOENoWWgzVVNLeHYzMWVjSU5WOFdCb3pFM3FzU0RaMlNCdmJwUmxCOUJUQzE0bXBpZTlCUXVxd2hyRWNNb1pOV2htSHFWcUVLYW16aExoNDJxYzNFTXNDY0xiclE3cDlPWnJOVUY4WlZacWJMdnA1VzFYbVFBVW8tUEpRdXc0VHlTS0ZMemZFQVd1NndTQ1YxYU1ndWJXdnBEajNFZlRpSTFqNDByZE5xVFhuRkd3ZU9mb1pHcW1n?oc=5","date":"2024-06-27","type":"pipeline","source":"European Medical Journal","summary":"Cold Agglutinin Disease (CAD) in the Clinic: Recognizing and addressing the impact of CAD beyond anemia - European Medical Journal","headline":"Cold Agglutinin Disease (CAD) in the Clinic: Recognizing and addressing the impact of CAD beyond anemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOZ2c3ZEFyMS13OXFVeV9pZ0ZISHZjNDZ3dXE3bTdPUUREVEo0dE5IQXlWTG1STjI3cVV1b3BVTjRYTWR2MGhmZGZQdkJneHBKNmxjTHl4SzhXQ1U3OV9UcjlORWtWVkhQLVB0b1pSc3dkUS1acjNkNzJIdUs2YUtpc3RDeWNDXzBQQndEdkhCNmFtb1JjYVRpcXdIeVVxMDg?oc=5","date":"2023-02-09","type":"pipeline","source":"PharmaTimes","summary":"Bio&Bio’s toxic shock syndrome vaccine research concluded - PharmaTimes","headline":"Bio&Bio’s toxic shock syndrome vaccine research concluded","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQZUJVTnhzaGZNQ2JVSGY4OUF0dzJWazNOWnJ0cDV6b19GUXVCX1c5bHdENDF4TWo0cVk4WWdFSWZvRzlTWFVMbVhVclQ1enVtYkl1LVg3LTQyMFZPVmJic0d5N285TWRSXzVtVW81eFFSdFQyR1k1Z2R3VU5ZQjZlMW03ay15bk9wWk5jeFVWSjRYMFdPVElYLQ?oc=5","date":"2016-06-14","type":"pipeline","source":"Fierce Pharma","summary":"Vienna group makes vaccine headway in toxic shock syndrome - Fierce Pharma","headline":"Vienna group makes vaccine headway in toxic shock syndrome","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}